October job gains could come in modestly higher than consensus given a positive seasonal adjustment factor, recent economic trends, and possible tailwinds from construction and retail.
A new CEO, a $5 billion share-repurchase program, and a handful of promising new drugs make Pfizer shares look cheap even after today's runup, according to Morningstar's Damien Conover.
First Trust Advisors chief economist Brian Wesbury on the current intensity of the housing downturn, the European sovereign debt crisis, unemployment, and consumer confidence.
A revitalized housing market, better-than-expected manufacturing data, and favorable seasonal adjustment factors could give a modest boost to September employment, says Morningstar's Bob Johnson.
Good morning, and welcome to The McGraw-Hill Companies' Conference Call. I'd like to inform you that this call is being recorded for broadcast. All participants are on a listen-only mode. We will open the conference to questions and answers after the presentation and instructions will follow at ...
Ladies and gentlemen, thank you for standing by. Welcome to the Thomson Reuters Third Quarter 2012 Earnings Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will be given at that time. As a reminder, today's ...